Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, is showcasing its latest cardiac care innovations at the European Society of Cardiology ESC ...
VASCEPA is the first and only agent studied on top of statin therapy reported to exhibit coronary plaque regression in hypertriglyceridemic patients VASCEPA in REDUCE-IT® cardiovascular outcomes study ...
Cath Lab Dispatch is TCTMD’s monthly roundup of recent news tidbits from journals and medical meetings around the globe. European Society of Cardiology (ESC) Congress 2020 As reported by TCTMD, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results